Ivermectin still not for distribution despite FDA’s compassionate use approval, according to Domingo.
Food and Drug Administration (FDA) Director-General Eric Domingo said that Ivermectin was still not for distribution despite the FDA approval of a hospital’s application for a compassionate use permit.
In a report on GMA News Online, Domingo said that the distribution of human grade Ivermectin as part of treatment for COVID-19 was still prohibited despite the FDA approval of a hospital’s application for a compassionate use permit.
Domingo said in an interview on Super Radyo dzBB that only the hospital that had the permit for Ivermectin’s compassionate use for humans will be allowed to import the said drug through a licensed importer.
Also, Domingo explained that doctors who asked for the compassionate use permit will be obliged to list down the COVID-positive patients who will be taking Ivermectin and will report its effects to the Food and Drug Administration.
“Yung ospital ang bibili, meron siyang licensed importer na magi-import para sa kaniya nitong gamot na ito na rehistrado sa ibang bansa. The doctor takes full responsibility for the product,” Domingo said.
Aside from this, the Food and Drug Administration approved the use of China’s Sinovac COVID-19 vaccine on senior citizens in the Philippines.
According to the Food and Drug Administration, the efficacy rate of China’s Sinovac COVID-19 vaccine on elderly people was “at least 51 percent”. However, the said vaccine shouldn’t be given to senior citizens with uncontrolled hypertension and acute illness.
Meanwhile, the Department of Health said in a statement that the Philippines temporarily suspended the use of the AstraZeneca COVID-19 vaccine on Filipinos younger than 60 years old, following reports of rare blood clots with low platelet counts in several recipients overseas.